This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Simmons, A Articles by Nash, A A Search for Related Content PubMed PubMed Citation Articles by Simmons, A Articles by Nash, A A

 Previous Article  |  Next Article 

J Virol. 1985 March; 53(3): 944-948

Role of antibody in primary and recurrent herpes simplex virus infection.

ABSTRACT

When herpes simplex virus was inoculated into the flank of a BALB/c mouse by scarification, the local replication of virus was followed by the establishment of an acute ganglionic infection. The subsequent centrifugal spread of this virus along nerves to the skin of the whole dermatome led to the development of a bandlike "zosteriform" rash. This represents a highly reproducible system in which virus travels through the nervous system synchronously in large numbers of animals. The transection of peripheral nerves at various times after infection showed that the virus had completed the round trip 60 h after inoculation into the upper flank and was detectable as infectious virus by 74 h postinfection. After the administration of virus, neutralizing but not nonneutralizing antibodies prevented the development of the zosteriform rash. The target epitopes of the protective antibodies were not confined to a single glycoprotein. Neutralizing antibody was effective even when given up to 60 h postinfection and was protective even when administered after sensory neurotomy at this time. Antibody was therefore able to prevent clinically and virologically detectable infection of the skin, presumably by acting peripherally on virus emerging from nerve endings. A quantitative estimate of the action of one of the neutralizing monoclonal antibody preparations, AP7, showed that high titers (several times higher than those normally found in immune mice) were needed to prevent this type of infection. These results are discussed in relation to antibody prophylaxis.

This article has been cited by other articles:

• Milligan, G. N., Meador, M. G., Chu, C.-F., Young, C. G., Martin, T. L., Bourne, N. (2005). Long-Term Presence of Virus-Specific Plasma Cells in Sensory Ganglia and Spinal Cord following Intravaginal Inoculation of Herpes Simplex Virus Type 2. J. Virol. 79: 11537-11540 [Abstract] [Full Text]  
• van Lint, A., Ayers, M., Brooks, A. G., Coles, R. M., Heath, W. R., Carbone, F. R. (2004). Herpes Simplex Virus-Specific CD8+ T Cells Can Clear Established Lytic Infections from Skin and Nerves and Can Partially Limit the Early Spread of Virus after Cutaneous Inoculation. J. Immunol. 172: 392-397 [Abstract] [Full Text]  
• Verschoor, A., Brockman, M. A., Gadjeva, M., Knipe, D. M., Carroll, M. C. (2003). Myeloid C3 Determines Induction of Humoral Responses to Peripheral Herpes Simplex Virus Infection. J. Immunol. 171: 5363-5371 [Abstract] [Full Text]  
• Connolly, S. A., Landsburg, D. J., Carfi, A., Wiley, D. C., Cohen, G. H., Eisenberg, R. J. (2003). Structure-Based Mutagenesis of Herpes Simplex Virus Glycoprotein D Defines Three Critical Regions at the gD-HveA/HVEM Binding Interface. J. Virol. 77: 8127-8140 [Abstract] [Full Text]  
• Grubor-Bauk, B., Simmons, A., Mayrhofer, G., Speck, P. G. (2003). Impaired Clearance of Herpes Simplex Virus Type 1 From Mice Lacking CD1d or NKT Cells Expressing the Semivariant V{alpha}14-J{alpha}281 TCR. J. Immunol. 170: 1430-1434 [Abstract] [Full Text]  
• Verschoor, A., Brockman, M. A., Knipe, D. M., Carroll, M. C. (2001). Cutting Edge: Myeloid Complement C3 Enhances the Humoral Response To Peripheral Viral Infection. J. Immunol. 167: 2446-2451 [Abstract] [Full Text]  
• Summers, B. C., Margolis, T. P., Leib, D. A. (2001). Herpes Simplex Virus Type 1 Corneal Infection Results in Periocular Disease by Zosteriform Spread. J. Virol. 75: 5069-5075 [Abstract] [Full Text]  
• Westra, D. F., Verjans, G. M. G. M., Osterhaus, A. D. M. E., van Kooij, A., Welling, G. W., Scheffer, A. J., The, T. H., Welling-Wester, S. (2000). Natural infection with herpes simplex virus type 1 (HSV-1) induces humoral and T cell responses to the HSV-1 glycoprotein H:L complex. J. Gen. Virol. 81: 2011-2015 [Abstract] [Full Text]  
• Nash, A. A. (2000). T Cells and the Regulation of Herpes Simplex Virus Latency and Reactivation. J. Exp. Med. 191: 1455-1458 [Full Text]  
• Thompson, R. L., Sawtell, N. M. (2000). Replication of Herpes Simplex Virus Type 1 within Trigeminal Ganglia Is Required for High Frequency but Not High Viral Genome Copy Number Latency. J. Virol. 74: 965-974 [Abstract] [Full Text]  
• Nagashunmugam, T., Lubinski, J., Wang, L., Goldstein, L. T., Weeks, B. S., Sundaresan, P., Kang, E. H., Dubin, G., Friedman, H. M. (1998). In Vivo Immune Evasion Mediated by the Herpes Simplex Virus Type 1 Immunoglobulin G Fc Receptor. J. Virol. 72: 5351-5359 [Abstract] [Full Text]  
• Peng, T., Ponce-de-Leon, M., Jiang, H., Dubin, G., Lubinski, J. M., Eisenberg, R. J., Cohen, G. H. (1998). The gH-gL Complex of Herpes Simplex Virus (HSV) Stimulates Neutralizing Antibody and Protects Mice against HSV Type 1 Challenge. J. Virol. 72: 65-72 [Abstract] [Full Text]